New Zealand markets close in 39 minutes

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
143.68-0.19 (-0.13%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close143.87
Open144.06
Bid143.51 x 800
Ask143.75 x 1200
Day's range142.86 - 144.17
52-week range109.16 - 157.00
Volume7,350,070
Avg. volume6,712,861
Market cap378.243B
Beta (5Y monthly)0.69
PE ratio (TTM)22.59
EPS (TTM)6.36
Earnings date26 Jan 2021
Forward dividend & yield4.04 (2.81%)
Ex-dividend date23 Nov 2020
1y target est166.18
  • 3 Stocks to Help You Build Retirement Wealth
    Motley Fool

    3 Stocks to Help You Build Retirement Wealth

    This basket of three dividend stocks contains an e-commerce leader and a potential coronavirus vaccine leader.

  • Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU
    Motley Fool

    Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU

    Score another pre-approval sale for coronavirus vaccine-maker Moderna (NASDAQ: MRNA). European Commission President Ursula von der Leyen has announced that the EC will ink a deal with the company on Wednesday. The contract will allow the European Union's member countries to purchase up to 160 million doses of Moderna's COVID-19 vaccine, mRNA-1273, once the vaccine is approved by EU regulators.

  • How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?
    Zacks

    How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?

    Interim data from late-stage studies on AstraZeneca (AZN) COVID-19 vaccine shows that the candidate was, on an average, about 70% effective in preventing COVID-19.